CELZ
Price
$2.48
Change
+$0.09 (+3.77%)
Updated
Jun 9, 02:02 PM (EDT)
Capitalization
6.18M
DARE
Price
$3.11
Change
-$0.09 (-2.81%)
Updated
Jun 9, 02:10 PM (EDT)
Capitalization
28.32M
Interact to see
Advertisement

CELZ vs DARE

Header iconCELZ vs DARE Comparison
Open Charts CELZ vs DAREBanner chart's image
Creative Medical Technology Holdings
Price$2.48
Change+$0.09 (+3.77%)
Volume$9.88K
Capitalization6.18M
Dare Bioscience
Price$3.11
Change-$0.09 (-2.81%)
Volume$254
Capitalization28.32M
CELZ vs DARE Comparison Chart
Loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELZ vs. DARE commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a StrongBuy and DARE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CELZ: $1.97 vs. DARE: $2.87)
Brand notoriety: CELZ and DARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELZ: 26% vs. DARE: 106%
Market capitalization -- CELZ: $6.18M vs. DARE: $28.32M
CELZ [@Biotechnology] is valued at $6.18M. DARE’s [@Biotechnology] market capitalization is $28.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileDARE’s FA Score has 0 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • DARE’s FA Score: 0 green, 5 red.
According to our system of comparison, CELZ is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 2 TA indicator(s) are bullish while DARE’s TA Score has 3 bullish TA indicator(s).

  • CELZ’s TA Score: 2 bullish, 4 bearish.
  • DARE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CELZ is a better buy in the short-term than DARE.

Price Growth

CELZ (@Biotechnology) experienced а -0.51% price change this week, while DARE (@Biotechnology) price change was -0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.68%. For the same industry, the average monthly price growth was +19.57%, and the average quarterly price growth was +6.76%.

Industries' Descriptions

@Biotechnology (+10.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DARE($28.3M) has a higher market cap than CELZ($6.18M). DARE YTD gains are higher at: -8.013 vs. CELZ (-14.719). CELZ has higher annual earnings (EBITDA): -5.63M vs. DARE (-23.19M). DARE has more cash in the bank: 11.2M vs. CELZ (5.94M). DARE has less debt than CELZ: DARE (1.4M) vs CELZ (2.74M). DARE has higher revenues than CELZ: DARE (1.88M) vs CELZ (11K).
CELZDARECELZ / DARE
Capitalization6.18M28.3M22%
EBITDA-5.63M-23.19M24%
Gain YTD-14.719-8.013184%
P/E RatioN/A0.10-
Revenue11K1.88M1%
Total Cash5.94M11.2M53%
Total Debt2.74M1.4M195%
FUNDAMENTALS RATINGS
CELZ vs DARE: Fundamental Ratings
CELZ
DARE
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6582
P/E GROWTH RATING
1..100
6178
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELZ's Valuation (59) in the null industry is in the same range as DARE (83) in the Biotechnology industry. This means that CELZ’s stock grew similarly to DARE’s over the last 12 months.

CELZ's Profit vs Risk Rating (100) in the null industry is in the same range as DARE (100) in the Biotechnology industry. This means that CELZ’s stock grew similarly to DARE’s over the last 12 months.

CELZ's SMR Rating (98) in the null industry is in the same range as DARE (100) in the Biotechnology industry. This means that CELZ’s stock grew similarly to DARE’s over the last 12 months.

CELZ's Price Growth Rating (65) in the null industry is in the same range as DARE (82) in the Biotechnology industry. This means that CELZ’s stock grew similarly to DARE’s over the last 12 months.

CELZ's P/E Growth Rating (61) in the null industry is in the same range as DARE (78) in the Biotechnology industry. This means that CELZ’s stock grew similarly to DARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELZDARE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 13 days ago
76%
Momentum
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
76%
MACD
ODDS (%)
N/A
Bearish Trend 13 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
79%
Bearish Trend 13 days ago
77%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 22 days ago
76%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 29 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 13 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with HOOK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
-3.90%
HOOK - CELZ
41%
Loosely correlated
-0.32%
DARE - CELZ
41%
Loosely correlated
+2.50%
RIGL - CELZ
40%
Loosely correlated
-2.19%
AZTR - CELZ
37%
Loosely correlated
-3.45%
PHIO - CELZ
35%
Loosely correlated
+16.96%
More

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with RIGL. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+2.50%
RIGL - DARE
88%
Closely correlated
-2.19%
CLNN - DARE
88%
Closely correlated
+0.76%
HOOK - DARE
87%
Closely correlated
-0.32%
PHIO - DARE
81%
Closely correlated
+16.96%
AZTR - DARE
78%
Closely correlated
-3.45%
More